EP4241767
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
Zusammenfassung
[0001] The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells.
Anmelder
ARBUTUS BIOPHARMA CORP [CA]
Erfinder
MANOHARAN MUTHIAH [US]JAYARAMAN MUTHUSAMY [US]RAJEEV KALLANTHOTTATHIL G [US]ELTEPU LAXMAN [US]ANSELL STEVEN [US]CHEN JIANXIN [US]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 31/01A61K 31/7088A61K 31/713A61K 39/00A61K 47/00A61K 9/127A61P 33/00A61P 35/00A61P 37/04C07D 203/10C07D 317/28C07D 317/44C07D 317/46C07D 317/72C07D 319/06C07D 405/12C07D 491/056C07D 491/113C12N 15/11
CPC-Klassen
A61K 31/7088A61K 31/7105A61K 31/713A61K 39/00A61K 39/39A61K 47/10A61K 47/18A61K 47/20A61K 47/22A61K 47/24A61K 47/28A61K 47/44A61K 48/0033A61K 9/1272A61K 9/5123A61P 33/00A61P 35/00A61P 37/04C07C 211/21C07C 217/46C07C 219/10C07C 229/08C07C 229/30C07C 237/16C07C 251/38C07C 251/78C07C 259/06C07C 271/12C07C 271/20C07C 279/04C07C 305/14C07C 307/06C07C 311/11C07C 323/25C07C 323/27C07C 327/06C07D 203/10C07D 211/72C07D 317/28C07D 317/44C07D 317/46C07D 317/72C07D 319/06C07D 405/12C07D 491/056C07D 491/113C07F 9/091C07F 9/1651C12N 15/111C12N 15/113
AI: Life SciencesChemistry
warum
A61K31/A61K47/A61K9/127 + A61P (multiple therapeutic classes) drive Life Science (lipid-nanoparticle drug delivery, Arbutus). C07D heterocyclic-chemistry IPCs support a secondary Chemistry tag for the novel lipid synthesis.